The New Money
LH

Labcorp

NYSE USD
$265.13
Market history
Loading chart…Fetching market history.

About Labcorp

Labcorp Holdings Inc. is a North Carolina-based diagnostics and drug development company that provides laboratory testing services to healthcare providers, pharmaceutical firms, researchers and patients. The company operates through two primary segments: a diagnostics network supporting clinical testing for physicians and health systems, and a biopharma laboratory services arm that supports drug development and clinical trials for life sciences customers.

Its diagnostics infrastructure includes patient service centers, in-office phlebotomists and hospital lab management agreements, giving the company broad reach across outpatient and inpatient settings. The biopharma segment partners with pharmaceutical and biotechnology companies on clinical trial logistics, central lab services and specialty testing across therapeutic areas including oncology, neurology and infectious disease.

Labcorp operates in more than 100 countries and continues to expand its testing menu through investments in biomarker discovery, oncology diagnostics and companion testing capabilities. Within the broader healthcare services landscape, the company sits alongside other large reference labs and contract research organizations that connect routine clinical testing with the data infrastructure used in pharmaceutical research and population health.

Similar to Labcorp

More Companies →

Why Labcorp Matters

Labcorp operates at the intersection of clinical diagnostics and life sciences research, a segment shaped by aging populations, expanding use of genomic testing and growing demand for outsourced drug development support. Reference labs and contract research organizations serve as connective tissue between providers, payers and pharmaceutical pipelines. Readers tracking this space can explore developments across the biotech sector for context on how diagnostics fits into broader life sciences markets.